Market by Therapy Type, Type of Disease, Route of Administration, and Geography | Forecast 2021-2028
Triton Market Research’s report on the global hormone replacement therapy market predicts that, based on revenue, the market is set to grow at a CAGR of 7.75% during the forecasting years 2021-2028. The market acquired revenue worth $17.44 billion in 2020, and is likely to garner $32.34 billion by 2028.
Report scope can be customized per your requirements. Request For Customization
Hormone replacement therapy
replaces hormones such as testosterone, human growth, thyroid, estrogen, and
progestogen that are at a lower level in the body.
The rising incidence of
growth hormone-related disorders such as Prader-Willi syndrome is expected to
drive the studied market’s growth. Prader-Willi disorder affects one in every
15,000 infants, thereby boosting the demand for growth hormone replacement therapy.
Moreover, rising cases of osteoporosis due to hormonal imbalance during
menopause and increasing prevalence of male hypogonadism are further expected
to contribute towards the market’s growth. Other than this, an increase in
growth deficiencies in the infant population over the past few years is
anticipated to boost the hormone replacement market’s progress.
Triton’s study aims to get an
overview of the hormone replacement therapy market in terms of various factors.
Within this report, the key insight and the market summary regarding the market
have been discussed. Also, the impact of COVID-19 on the market, Porter’s five
forces model, market attractiveness matrix, vendor scorecard, and key market
strategies have been studied in detail.
Major drivers like awareness
pertaining to health problems during menopause and new product launches by
major giants are driving the hormone replacement therapy market’s growth.
Additionally, the availability of alternative therapy, coupled with the launch
of telemedicine clinical practice services, are key elements offering growth
opportunities to the reviewed market.
However, the high cost of treatment and adverse reactions related to hormone replacement therapy are obstructing the studied market’s development.
Key geographies covered in the hormone
replacement therapy market are:
• North America: Canada and United States
• Europe: Russia, Spain, United Kingdom, Germany, France,
Italy, and Rest of Europe
• Asia-Pacific: Australia & New Zealand, Japan, India,
ASEAN countries, South Korea, China, and Rest of Asia-Pacific
• Latin America: Mexico, Brazil, and Rest of Latin America
• Middle East and Africa: United Arab Emirates, Turkey,
Saudi Arabia, South Africa, and Rest of Middle East & Africa
The market for hormone replacement therapy is
segmented as follows:
• Market by Therapy Type:
o Estrogen
Hormone Replacement Therapy
o Thyroid
Hormone Replacement Therapy
o Testosterone
Hormone Replacement Therapy
o Human
Growth Hormone Replacement Therapy
o Progestogen
Hormone Replacement Therapy
• Market by Type of Disease:
o Menopause
o Male
Hypogonadism
o Growth
Hormone Deficiency
o Hypothyroidism
o Other
Type of Diseases
• Market by Route of Administration:
o Oral
o Parenteral
o Transdermal
o Other
Routes of Administration
The distinguished players
engaged in the hormone replacement therapy market are Genentech Inc, Teva
Pharmaceutical Industries Ltd, Amgen, Noven Pharmaceuticals Inc, Bayer AG,
Viatris Inc (Mylan NV), Abbott Laboratories, Eli Lilly & Company, Merck KGAA,
ANI Pharmaceuticals, Novartis AG, Novo Nordisk A/S, Dr Reddy’s Laboratories
Ltd, Pfizer Inc, and Ipsen.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. GLOBAL
HORMONE REPLACEMENT THERAPY MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON HORMONE REPLACEMENT THERAPY MARKET
2.2. KEY
INSIGHTS
2.2.1. INTRODUCTION
OF NEW DRUG DELIVERY SYSTEMS FOR HORMONE REPLACEMENT
2.2.2. MODERN
SEDENTARY LIFESTYLES
2.3. PORTER’S
FIVE FORCES MODEL
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE PRODUCTS
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. COMPETITIVE
RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. KEY
STRATEGIC DEVELOPMENTS
2.6.1. ACQUISITIONS
& MERGERS
2.6.2. PRODUCT
LAUNCH & DEVELOPMENTS
2.6.3. CONTRACTS
AND PARTNERSHIPS
2.6.4. BUSINESS
EXPANSIONS, ANNOUNCEMENTS, & DIVESTITURES
2.7. MARKET
DRIVERS
2.7.1. RISE
IN AWARENESS PERTAINING TO HEALTH PROBLEMS DURING MENOPAUSE
2.7.2. INCREASE
IN PREVALENCE OF HORMONAL DISORDERS
2.7.3. NEW
PRODUCT LAUNCHES BY MAJOR GIANTS
2.8. MARKET
RESTRAINTS
2.8.1. HIGH
COST OF TREATMENT
2.8.2. ADVERSE
REACTIONS ASSOCIATED WITH HORMONE REPLACEMENT THERAPY
2.9. MARKET
OPPORTUNITIES
2.9.1. AVAILABILITY
OF ALTERNATIVE THERAPY OFFERS OPPORTUNITIES FOR THE MARKET’S GROWTH
2.9.2. LAUNCH
OF TELEMEDICINE CLINICAL PRACTICE SERVICES
3. GLOBAL
HORMONE REPLACEMENT THERAPY MARKET - BY THERAPY TYPE
3.1. ESTROGEN
HORMONE REPLACEMENT THERAPY
3.2. THYROID
HORMONE REPLACEMENT THERAPY
3.3. TESTOSTERONE
HORMONE REPLACEMENT THERAPY
3.4. HUMAN
GROWTH HORMONE REPLACEMENT THERAPY
3.5. PROGESTOGEN
HORMONE REPLACEMENT THERAPY
4. GLOBAL
HORMONE REPLACEMENT THERAPY MARKET - BY TYPE OF DISEASE
4.1. MENOPAUSE
4.2. MALE
HYPOGONADISM
4.3. GROWTH
HORMONE DEFICIENCY
4.4. HYPOTHYROIDISM
4.5. OTHER
TYPE OF DISEASES
5. GLOBAL
HORMONE REPLACEMENT THERAPY MARKET - BY ROUTE OF ADMINISTRATION
5.1. ORAL
5.2. PARENTERAL
5.3. TRANSDERMAL
5.4. OTHER
ROUTES OF ADMINISTRATION
6. GLOBAL
HORMONE REPLACEMENT THERAPY MARKET – REGIONAL OUTLOOK
6.1. NORTH
AMERICA
6.1.1. MARKET
BY THERAPY TYPE
6.1.2. MARKET
BY TYPE OF DISEASE
6.1.3. MARKET
BY ROUTE OF ADMINISTRATION
6.1.4. COUNTRY
ANALYSIS
6.1.4.1. UNITED
STATES
6.1.4.2. CANADA
6.2. EUROPE
6.2.1. MARKET
BY THERAPY TYPE
6.2.2. MARKET
BY TYPE OF DISEASE
6.2.3. MARKET
BY ROUTE OF ADMINISTRATION
6.2.4. COUNTRY
ANALYSIS
6.2.4.1. GERMANY
6.2.4.2. FRANCE
6.2.4.3. UNITED
KINGDOM
6.2.4.4. ITALY
6.2.4.5. RUSSIA
6.2.4.6. SPAIN
6.2.4.7. REST
OF EUROPE
6.3. ASIA-PACIFIC
6.3.1. MARKET
BY THERAPY TYPE
6.3.2. MARKET
BY TYPE OF DISEASE
6.3.3. MARKET
BY ROUTE OF ADMINISTRATION
6.3.4. COUNTRY
ANALYSIS
6.3.4.1. CHINA
6.3.4.2. JAPAN
6.3.4.3. INDIA
6.3.4.4. AUSTRALIA
& NEW ZEALAND
6.3.4.5. SOUTH
KOREA
6.3.4.6. ASEAN
COUNTRIES
6.3.4.7. REST
OF ASIA-PACIFIC
6.4. LATIN
AMERICA
6.4.1. MARKET
BY THERAPY TYPE
6.4.2. MARKET
BY TYPE OF DISEASE
6.4.3. MARKET
BY ROUTE OF ADMINISTRATION
6.4.4. COUNTRY
ANALYSIS
6.4.4.1. MEXICO
6.4.4.2. BRAZIL
6.4.4.3. REST
OF LATIN AMERICA
6.5. MIDDLE
EAST AND AFRICA
6.5.1. MARKET
BY THERAPY TYPE
6.5.2. MARKET
BY TYPE OF DISEASE
6.5.3. MARKET
BY ROUTE OF ADMINISTRATION
6.5.4. COUNTRY
ANALYSIS
6.5.4.1. SAUDI
ARABIA
6.5.4.2. UNITED
ARAB EMIRATES
6.5.4.3. TURKEY
6.5.4.4. SOUTH
AFRICA
6.5.4.5. REST
OF MIDDLE EAST & AFRICA
7. COMPETITIVE
LANDSCAPE
7.1. ABBOTT
LABORATORIES
7.2. AMGEN
7.3. ANI
PHARMACEUTICALS
7.4. BAYER
AG
7.5. DR
REDDY’S LABORATORIES LTD
7.6. ELI
LILLY & COMPANY
7.7. GENENTECH
INC
7.8. IPSEN
7.9. MERCK
KGAA
7.10. NOVARTIS
AG
7.11. NOVEN
PHARMACEUTICALS INC
7.12. NOVO
NORDISK A/S
7.13. PFIZER
INC
7.14. TEVA
PHARMACEUTICAL INDUSTRIES LTD
7.15. VIATRIS
INC (MYLAN NV)
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.1.1. OBJECTIVES
OF STUDY
8.1.2. SCOPE
OF STUDY
8.2. SOURCES
OF DATA
8.2.1. PRIMARY
DATA SOURCES
8.2.2. SECONDARY
DATA SOURCES
8.3. RESEARCH
METHODOLOGY
8.3.1. EVALUATION
OF PROPOSED MARKET
8.3.2. IDENTIFICATION
OF DATA SOURCES
8.3.3. ASSESSMENT
OF MARKET DETERMINANTS
8.3.4. DATA
COLLECTION
8.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: GLOBAL HORMONE REPLACEMENT THERAPY
MARKET, BY REGION, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LIST OF ACQUISITIONS & MERGERS
TABLE 4: LIST OF PRODUCT LAUNCHES &
DEVELOPMENTS
TABLE 5: LIST OF CONTRACTS AND PARTNERSHIPS
TABLE 6: LIST OF BUSINESS EXPANSIONS,
ANNOUNCEMENTS, AND DIVESTITURES
TABLE 7: GLOBAL HORMONE REPLACEMENT THERAPY
MARKET, BY THERAPY TYPE, 2021-2028 (IN $ MILLION)
TABLE 8: GLOBAL HORMONE REPLACEMENT THERAPY
MARKET, BY TYPE OF DISEASE, 2021-2028 (IN $ MILLION)
TABLE 9: GLOBAL HORMONE REPLACEMENT THERAPY
MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (IN $ MILLION)
TABLE 10: GLOBAL HORMONE REPLACEMENT THERAPY MARKET,
BY REGION, 2021-2028 (IN $ MILLION)
TABLE 11: NORTH AMERICA HORMONE REPLACEMENT THERAPY
MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 12: NORTH AMERICA HORMONE REPLACEMENT THERAPY
MARKET, BY THERAPY TYPE, 2021-2028 (IN $ MILLION)
TABLE 13: NORTH AMERICA HORMONE REPLACEMENT THERAPY
MARKET, BY TYPE OF DISEASE, 2021-2028 (IN $ MILLION)
TABLE 14: NORTH AMERICA HORMONE REPLACEMENT THERAPY
MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (IN $ MILLION)
TABLE 15: EUROPE HORMONE REPLACEMENT THERAPY, BY
COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 16: EUROPE HORMONE REPLACEMENT THERAPY MARKET,
BY THERAPY TYPE, 2021-2028 (IN $ MILLION)
TABLE 17: EUROPE HORMONE REPLACEMENT THERAPY MARKET,
BY TYPE OF DISEASE, 2021-2028 (IN $ MILLION)
TABLE 18: EUROPE HORMONE REPLACEMENT THERAPY MARKET,
BY ROUTE OF ADMINISTRATION, 2021-2028 (IN $ MILLION)
TABLE 19: ASIA-PACIFIC HORMONE REPLACEMENT THERAPY
MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 20: ASIA-PACIFIC HORMONE REPLACEMENT THERAPY
MARKET, BY THERAPY TYPE, 2021-2028 (IN $ MILLION)
TABLE 21: ASIA-PACIFIC HORMONE REPLACEMENT THERAPY
MARKET, BY TYPE OF DISEASE, 2021-2028 (IN $ MILLION)
TABLE 22: ASIA-PACIFIC HORMONE REPLACEMENT THERAPY
MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (IN $ MILLION)
TABLE 23: LATIN AMERICA HORMONE REPLACEMENT THERAPY
MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 24: LATIN AMERICA HORMONE REPLACEMENT THERAPY
MARKET, BY THERAPY TYPE, 2021-2028 (IN $ MILLION)
TABLE 25: LATIN AMERICA HORMONE REPLACEMENT THERAPY
MARKET, BY TYPE OF DISEASE, 2021-2028 (IN $ MILLION)
TABLE 26: LATIN AMERICA HORMONE REPLACEMENT THERAPY
MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (IN $ MILLION)
TABLE 27: MIDDLE EAST AND AFRICA HORMONE REPLACEMENT
THERAPY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 28: MIDDLE EAST AND AFRICA HORMONE REPLACEMENT
THERAPY MARKET, BY THERAPY TYPE, 2021-2028 (IN $ MILLION)
TABLE 29: MIDDLE EAST AND AFRICA HORMONE REPLACEMENT
THERAPY MARKET, BY TYPE OF DISEASE, 2021-2028 (IN $ MILLION)
TABLE 30: MIDDLE EAST AND AFRICA HORMONE REPLACEMENT
THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (IN $ MILLION)
FIGURE 1: GLOBAL HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 2: GLOBAL HORMONE
REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, 2020 & 2028 (IN %)
FIGURE 3: GLOBAL HORMONE
REPLACEMENT THERAPY MARKET, BY ESTROGEN HORMONE REPLACEMENT THERAPY, 2021-2028
(IN $ MILLION)
FIGURE 4: GLOBAL HORMONE
REPLACEMENT THERAPY MARKET, BY THYROID HORMONE REPLACEMENT THERAPY, 2021-2028
(IN $ MILLION)
FIGURE 5: GLOBAL HORMONE
REPLACEMENT THERAPY MARKET, BY TESTOSTERONE HORMONE REPLACEMENT THERAPY,
2021-2028 (IN $ MILLION)
FIGURE 6: GLOBAL HORMONE
REPLACEMENT THERAPY MARKET, BY HUMAN GROWTH HORMONE REPLACEMENT THERAPY,
2021-2028 (IN $ MILLION)
FIGURE 7: GLOBAL HORMONE
REPLACEMENT THERAPY MARKET, BY PROGESTOGEN HORMONE REPLACEMENT THERAPY,
2021-2028 (IN $ MILLION)
FIGURE 8: GLOBAL HORMONE
REPLACEMENT THERAPY MARKET, BY TYPE OF DISEASE, 2020 & 2028 (IN %)
FIGURE 9: GLOBAL HORMONE
REPLACEMENT THERAPY MARKET, BY MENOPAUSE, 2021-2028 (IN $ MILLION)
FIGURE 10: GLOBAL HORMONE
REPLACEMENT THERAPY MARKET, BY MALE HYPOGONADISM, 2021-2028 (IN $ MILLION)
FIGURE 11: GLOBAL HORMONE
REPLACEMENT THERAPY MARKET, BY GROWTH HORMONE DEFICIENCY, 2021-2028 (IN $
MILLION)
FIGURE 12: GLOBAL HORMONE
REPLACEMENT THERAPY MARKET, BY HYPOTHYROIDISM, 2021-2028 (IN $ MILLION)
FIGURE 13: GLOBAL HORMONE REPLACEMENT
THERAPY MARKET, BY OTHER TYPE OF DISEASES, 2021-2028 (IN $ MILLION)
FIGURE 14: GLOBAL HORMONE
REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2020 & 2028 (IN %)
FIGURE 15: GLOBAL HORMONE
REPLACEMENT THERAPY MARKET, BY ORAL, 2021-2028 (IN $ MILLION)
FIGURE 16: GLOBAL HORMONE
REPLACEMENT THERAPY MARKET, BY PARENTERAL, 2021-2028 (IN $ MILLION)
FIGURE 17: GLOBAL HORMONE
REPLACEMENT THERAPY MARKET, BY TRANSDERMAL, 2021-2028 (IN $ MILLION)
FIGURE 18: GLOBAL HORMONE
REPLACEMENT THERAPY MARKET, BY OTHER ROUTES OF ADMINISTRATION, 2021-2028 (IN $
MILLION)
FIGURE 19: UNITED STATES HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 20: CANADA HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 21: GERMANY HORMONE REPLACEMENT
THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 22: FRANCE HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 23: UNITED KINGDOM HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 24: ITALY HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 25: RUSSIA HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 26: SPAIN HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 27: REST OF EUROPE HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 28: CHINA HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 29: JAPAN HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 30: INDIA HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 31: AUSTRALIA & NEW
ZEALAND HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 32: SOUTH KOREA HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 33: ASEAN COUNTRIES HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 34: REST OF ASIA-PACIFIC
HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 35: MEXICO HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 36: BRAZIL HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 37: REST OF LATIN AMERICA
HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 38: SAUDI ARABIA HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 39: UNITED ARAB EMIRATES
HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 40: TURKEY HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 41: SOUTH AFRICA HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 42: REST OF MIDDLE EAST AND
AFRICA HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)